Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CHAT | P28329 | 2/20 | 0.85 |
| ▸ | NAA50 | Q9GZZ1 | 2/20 | 0.85 |
| ▸ | EP300 | Q09472 | 4/20 | 0.84 |
| ▸ | KAT5 | Q92993 | 2/20 | 0.84 |
| ▸ | AURKA | O14965 | 2/20 | 0.84 |
| ▸ | KAT2B | Q92831 | 1/20 | 0.84 |
| ▸ | CREBBP | Q92793 | 1/20 | 0.79 |
| ▸ | NAA40 | Q86UY6 | 1/20 | 0.78 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30991360 | 1.00 | CHAT (0.85) | CHATNAA50EP300KAT5AURKA | |
| SCHEMBL30361785 | 1.00 | CHAT (0.85) | CHATNAA50EP300KAT5AURKA | |
| SCHEMBL1370748 | 1.00 | CHAT (0.85) | CHATNAA50EP300KAT5AURKA | |
| SCHEMBL26700227 | 0.96 | EP300 (0.83) | CHATNAA50EP300KAT5AURKA | |
| SCHEMBL28803301 | 0.96 | EP300 (0.83) | CHATNAA50EP300KAT5AURKA | |
| SCHEMBL28670397 | 0.95 | CHAT (0.83) | CHATNAA50EP300KAT5AURKA | |
| SCHEMBL29366032 | 0.95 | NAA50 (0.84) | CHATNAA50EP300KAT5AURKA | |
| SCHEMBL28017929 | 0.94 | EP300 (0.84) | CHATNAA50EP300KAT5AURKA | |
| SCHEMBL2112268 | 0.94 | CHAT (0.83) | CHATNAA50EP300KAT5AURKA | |
| SCHEMBL18608119 | 0.94 | CHAT (0.87) | CHATNAA50EP300KAT5AURKA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250163478-A1 | BIOCONVERSION OF LEVULINIC ACID IN GENETICALLY ENGINEERED HOSTS | WISCONSIN ALUMNI RESEARCH FOUNDATION (US) | 2025-05-22 | — | — | US | disclosed |
| US-12116609-B2 | Bioconversion of levulinic acid in genetically engineered hosts | WISCONSIN ALUMNI RESEARCH FOUNDATION (US) | 2024-10-15 | — | — | US | disclosed |
| US-20210155961-A1 | BIOCONVERSION OF LEVULINIC ACID IN GENETICALLY ENGINEERED HOSTS | NATIONAL SCIENCE FOUNDATION | 2021-05-27 | — | — | US | disclosed |
| US-10934563-B2 | Bioconversion of levulinic acid in genetically engineered hosts | WISCONSIN ALUMNI RESEARCH FOUNDATION (US) | 2021-03-02 | — | — | US | disclosed |
| US-20190085362-A1 | BIOCONVERSION OF LEVULINIC ACID IN GENETICALLY ENGINEERED HOSTS | NATIONAL SCIENCE FOUNDATION | 2019-03-21 | — | — | US | disclosed |